A Duke Health analysis of breast cancer in North Carolina has shown that the state's urban counties had higher overall incidences of disease than rural counties, especially at early stages upon diagnosis.
Nov 20, 2023
0
40
A new AI tool from Kheiron Medical Technologies and Imperial College London can detect up to 13% more breast cancers than humans in breast screenings.
Nov 20, 2023
0
47
The majority of breast cancers start in the lining of a breast milk duct and, if they remain there, are very treatable. But once these cancers become invasive—breaking through a thin matrix around the duct, called the basement ...
Nov 14, 2023
0
20
Intratumoral therapy—in which cancer drugs are injected directly into tumors—is a promising treatment option for solid cancers but has shown limited success in clinical trials due to an inability to precisely deliver ...
Nov 13, 2023
0
42
A research team led by the Nagoya University Graduate School of Medicine has discovered that the stromal cell-derived factor 4 (SDF-4) protein is a reliable cancer marker. As simple blood tests accurately detect the protein, ...
Nov 10, 2023
0
69
Breast cancer is the most common form of cancer among women, with more than 2 million new cases diagnosed each year. In cases where the tumor remains localized in the breast, survival rates are remarkably high, at around ...
Nov 9, 2023
0
26
A group of researchers led by the Francis Crick Institute, working with the National Physical Laboratory (NPL) and Imperial College London, have discovered that breast cancer cells expressing a cancer-driving gene heavily ...
Nov 9, 2023
0
34
Scientists at the Ontario Institute for Cancer Research (OICR) have uncovered one way tobacco smoking causes cancer and makes it harder to treat by undermining the body's anti-cancer safeguards.
Nov 3, 2023
0
282
Researchers at MUSC Hollings Cancer Center believe that some drugs already approved by the FDA or currently in clinical trials could be repurposed for certain breast cancer patients whose cancer has become resistant to standard ...
Nov 2, 2023
0
42
A pioneering study led by Professor Ashok Venkitaraman from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore and Dr. Mona Shehata from the University of Cambridge (UK) has ...
Nov 2, 2023
0
23
